Target intelligence / Profile preview

Intracellular calcium handling pathways in smooth and skeletal muscle (ECC) (ECC)

Target
ECC
Molecular classification
Ion channel, Transporter, Enzyme, Signaling pathway
01

Overview

Intracellular calcium (Ca2+) handling pathways in smooth and skeletal muscle are complex systems responsible for regulating the concentration of cytosolic calcium to facilitate muscle contraction and relaxation. In skeletal muscle, the process is initiated by excitation-contraction coupling, where the dihydropyridine receptor (DHPR) senses membrane depolarization and triggers Ca2+ release from the sarcoplasmic reticulum (SR) through the ryanodine receptor 1 (RyR1) (StatPearls, 2023). Smooth muscle calcium handling involves both extracellular Ca2+ influx via voltage-gated channels and intracellular release mediated by inositol trisphosphate (IP3) receptors (NCBI, 2021). Proper functioning of these pathways is critical, as dysregulation can lead to life-threatening conditions such as malignant hyperthermia or chronic muscle weakness (PubMed, 2022). Pharmacological agents like dantrolene target these pathways by inhibiting RyR1 to treat hypermetabolic crises, while calcium channel blockers are used to manage smooth muscle tone in cardiovascular diseases (PubChem, 2024). The sarcoplasmic/endoplasmic reticulum calcium ATPase (SERCA) pump also plays a vital role by sequestering Ca2+ back into the SR to allow for muscle relaxation. Understanding these pathways is vital for developing therapies for genetic myopathies and vascular disorders.

Other names
Excitation-contraction couplingCalcium signalingSarcoplasmic reticulum calcium cyclingCalcium homeostasis
02

Mechanism of action

Modulation of calcium release from the sarcoplasmic reticulum via ryanodine receptors, inhibition of L-type voltage-gated calcium channels, or inhibition of the sarcoplasmic/endoplasmic reticulum calcium ATPase (SERCA) pump.

03

Biological functions

Muscle contractionSignal transductionCalcium homeostasisExcitation-contraction coupling
04

Disease associations

Malignant hyperthermiaCentral core diseaseBrody diseaseHypertensionMyopathy
05

Safety considerations

HepatotoxicityMuscle weaknessCardiac arrhythmiasHypotensionRespiratory depression
06

Interacting drugs

Dantrolene

4 more in the full profile.

07

Biomarkers

Cytosolic Ca2+ concentrationCreatine kinase levelsRYR1 gene mutationsATP2A1 gene mutations

Beyond the preview

Go deeper on Intracellular calcium handling pathways in smooth and skeletal muscle (ECC) (ECC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intracellular calcium handling pathways in smooth and skeletal muscle (ECC) (ECC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call